Igor D'angelo

Title: Igor D'angelo: Innovator in Antibody Constructs

Introduction

Igor D'angelo is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibody constructs. His innovative work has implications for medical applications and therapeutic advancements.

Latest Patents

Igor D'angelo holds a patent for MAGEB2 binding constructs. This invention relates to antibody constructs that comprise a domain binding to a MAGEB2 peptide complexed with an HLA, and optionally, another domain that binds to CD3. The invention also includes polynucleotides encoding these antibody constructs, vectors containing said polynucleotides, and host cells transformed or transfected with these polynucleotides or vectors. Additionally, the invention outlines processes for producing the antibody constructs, their medical uses, and kits that include these constructs.

Career Highlights

Throughout his career, Igor has worked with prominent companies in the biotechnology sector. He has been associated with Amgen Inc. and Amgen Research (Munich) GmbH, where he has contributed to various research and development projects.

Collaborations

Igor has collaborated with several professionals in his field, including Ian Nevin Foltz and Weihsu Claire Chen. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Igor D'angelo's work in antibody constructs represents a significant advancement in biotechnology. His contributions have the potential to impact medical treatments and therapeutic strategies.